Scandinavian Journal of Clinical and Laboratory Investigation · 2018 · 10 citations · 19 references
Veterinary MedicineImmunologyInfectious DiseasesInflammationInnate ImmunitySepsisBiomarkers In SepsisInflammatory BiomarkersSepsis DiagnosisSepsis PathophysiologySepsis PrognosisBiomarker-based Prognostic ModelsBiomarker-based Sepsis DiagnosisBiomarker-based Sepsis PrognosticationHost Response BiomarkersLaboratory-based PrognosticationPrognostic Marker AssessmentPrognostic Marker EvaluationSepsis Predictors
Sepsis is a leading cause of mortality. This study aims to assess the utility of the soluble mannose receptor (sMR) as a biomarker of sepsis and mortality in patients hospitalized with suspected infection. Using an in-house ELISA assay the concentration of sMR was analyzed in the serum of patients from three prospective studies. Using Sepsis-3 guidelines, patients were stratified as no infection (NI, n = 68), verified infection without sepsis (NSEP, n = 133) and verified infection with sepsis (SEP, n = 190). Adverse outcome was assessed as death before 28 days. We show that the sensitivity of sMR to predict mortality [area under curve (AUC) = 0.77] exceeded the sensitivity of procalcitonin (PCT, AUC = 0.63), C-reactive protein (CRP, AUC = 0.61) and the macrophage soluble receptor, CD163 (sCD163, AUC = 0.74), while it was less accurate to predict diagnosis of sepsis [AUC(sMR) = 0.69 vs. AUC(PCT) = 0.79, AUC(CRP) = 0.71 and AUC(sCD163) = 0.66]. Median sMR was significantly higher in the group with SEP (0.55 mg/L), compared with the groups without sepsis (NI and NSEP) (0.39 mg/L, p < .0001), and among those who died compared to those who survived (0.89 mg/L vs. 0.44 mg/L, p < .0001). Our results, and the current literature, support further evaluation of sMR as a biomarker of sepsis and mortality among patients hospitalized with suspected infection.
19
Assessment of Clinical Criteria for Sepsis
Christopher W. Seymour, Theodore J. Iwashyna, Frank M. Brunkhorst et al. · JAMA · 2016 · 3.8K citations · Full text
Veterinary Medicine, Infectious Diseases, Internal Medicine +17
Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis
Theodore J. Iwashyna, E. Wesley Ely, Dylan M. Smith et al. · JAMA · 2010 · 2.6K citations
Medicine, Neurology, Psychiatry +16